WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005067928) METHOD FOR TREATING ERECTILE DYSFUNCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/067928    International Application No.:    PCT/JP2005/000806
Publication Date: 28.07.2005 International Filing Date: 17.01.2005
IPC:
A61K 31/453 (2006.01)
Applicants: ASTELLAS PHARMA INC. [JP/JP]; 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411 (JP) (For All Designated States Except US).
YAMAJI, Takayuki [JP/JP]; (JP) (For US Only).
YAMAZAKI, Shunji [JP/JP]; (JP) (For US Only).
PRICE, Raymond [US/JP]; (JP) (For US Only)
Inventors: YAMAJI, Takayuki; (JP).
YAMAZAKI, Shunji; (JP).
PRICE, Raymond; (JP)
Agent: HAMAI, Kosuke; c/o Astellas Pharma Inc., Intellectual Property, 3-11, Nihobashi-Honcho, 2-chome, Chuo-ku, Tokyo 103-8411 (JP)
Priority Data:
60/537,014 20.01.2004 US
60/610,539 17.09.2004 US
Title (EN) METHOD FOR TREATING ERECTILE DYSFUNCTION
(FR) METHODE DE TRAITEMENT DES TROUBLES DE L'ERECTION
Abstract: front page image
(EN)Macrolide compound (I) is provided for treating or preventing erectile dysfunction, which is, for example, induced by or secondary to diseases, alcoholism, aging, arterial insufficiency, venous leakage, hormonal insufficiency, drug use, surgery, chemotherapy or radiation, particularly, for preventing or treating an erectile dysfunction of mammals.
(FR)L'invention concerne un composé macrolide (I) destiné à la prévention ou au traitement des troubles de l'érection provoqués, par exemple, ou consécutifs à des maladies, à l'alcoolisme, au vieillissement, à l'insuffisance artérielle, à la fuite veineuse, à l'insuffisance hormonale, à la consommation de drogues, à une opération chirurgicale, à une chimiothérapie ou à une radiothérapie, ledit composé permettant en particulier, de traiter ou de prévenir les troubles de l'érection chez les mammifères.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)